Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group.

N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.

PMID:
20818902
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.

Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, Lash J, Cornish-Zirker D, Peterson G, Toto R, Kusek J, Appel L, Kendrick C, Gassman J; AASK group.

Am J Kidney Dis. 2007 Jul;50(1):78-89, 89.e1.

PMID:
17591527
[PubMed - indexed for MEDLINE]
3.

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.

McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G.

J Am Soc Nephrol. 2006 Jun;17(6):1710-5. Epub 2006 Apr 26.

PMID:
16641151
[PubMed - indexed for MEDLINE]
Free Article
4.

The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.

Eriksen BO, Ingebretsen OC.

Kidney Int. 2006 Jan;69(2):375-82.

PMID:
16408129
[PubMed - indexed for MEDLINE]
5.

Regression of existing glomerulosclerosis by inhibition of aldosterone.

Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB.

J Am Soc Nephrol. 2005 Nov;16(11):3306-14. Epub 2005 Sep 28.

PMID:
16192423
[PubMed - indexed for MEDLINE]
Free Article
6.

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

Hsu CY, Lin F, Vittinghoff E, Shlipak MG.

J Am Soc Nephrol. 2003 Nov;14(11):2902-7.

PMID:
14569100
[PubMed - indexed for MEDLINE]
Free Article
7.

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

Ann Intern Med. 2003 Aug 19;139(4):244-52.

PMID:
12965979
[PubMed - indexed for MEDLINE]
8.

The rationale and design of the AASK cohort study.

Appel LJ, Middleton J, Miller ER 3rd, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S166-72.

PMID:
12819323
[PubMed - indexed for MEDLINE]
Free Article
9.

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

Gassman JJ, Greene T, Wright JT Jr, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS, Wang SR.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S154-65.

PMID:
12819322
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S148-53.

PMID:
12819321
[PubMed - indexed for MEDLINE]
Free Article
11.

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.

Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G.

J Am Soc Nephrol. 2002 Dec;13(12):2898-908.

PMID:
12444208
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group.

JAMA. 2002 Nov 20;288(19):2421-31. Erratum in: JAMA. 2006 Jun 21;295(23):2726.

PMID:
12435255
[PubMed - indexed for MEDLINE]
13.

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL.

J Am Soc Nephrol. 2002 Sep;13(9):2363-70.

PMID:
12191981
[PubMed - indexed for MEDLINE]
Free Article
14.

Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.

Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G.

Kidney Int. 2002 Jun;61(6):2066-77. Erratum in: Kidney Int 2002 Aug;62(2):731.

PMID:
12028447
[PubMed - indexed for MEDLINE]
Free Article
15.

ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.

Ruggenenti P, Perna A, Remuzzi G; Gruppo Italiano di Studi Epidemiologici in Nefrologia.

J Am Soc Nephrol. 2001 Dec;12(12):2832-7.

PMID:
11729254
[PubMed - indexed for MEDLINE]
Free Article
16.

Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr; African-American Study of Hypertension and Kidney Disease.

Am J Kidney Dis. 2001 Oct;38(4):744-53. Erratum in: Am J Kidney Dis 2002 Feb;39(2):444.

PMID:
11576877
[PubMed - indexed for MEDLINE]
17.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators.

N Engl J Med. 2001 Sep 20;345(12):861-9.

PMID:
11565518
[PubMed - indexed for MEDLINE]
Free Article
18.

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299.

PMID:
11453706
[PubMed - indexed for MEDLINE]
19.

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group.

JAMA. 2001 Jun 6;285(21):2719-28.

PMID:
11386927
[PubMed - indexed for MEDLINE]
20.

Progression and potential regression of glomerulosclerosis.

Fogo AB.

Kidney Int. 2001 Feb;59(2):804-19. No abstract available.

PMID:
11168971
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk